메뉴 건너뛰기




Volumn 21, Issue 5, 2006, Pages 1402-1406

Does haemodialysis significantly affect serum linezolid concentrations in critically ill patients with renal failure? A pilot investigation

Author keywords

Critical illness; Dosage guidelines; Haemodialysis; Linezolid; Renal failure

Indexed keywords

CEFTAZIDIME; CLAVULANIC ACID; DOBUTAMINE; LINEZOLID; METICILLIN; NORADRENALIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM;

EID: 33646193814     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl048     Document Type: Article
Times cited : (31)

References (13)
  • 1
    • 0037458217 scopus 로고    scopus 로고
    • Linezolid: The first oxazolidinone antimicrobial
    • Moellering RC. Linezolid: The first oxazolidinone antimicrobial. Ann Int Med 2003; 138: 135-142
    • (2003) Ann Int Med , vol.138 , pp. 135-142
    • Moellering, R.C.1
  • 2
    • 0038778571 scopus 로고    scopus 로고
    • Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with gram-positive infections
    • MacGowan AP. Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with gram-positive infections. J Antimicrob Chemoter 2003; 51 [Suppl S2]: Ii17-ii25
    • (2003) J Antimicrob Chemoter , vol.51 , Issue.SUPPL. S2
    • MacGowan, A.P.1
  • 3
    • 10744231747 scopus 로고    scopus 로고
    • Linezolid versus teicoplanin in the treatment of gram-positive infections in the critically ill: A randomised, double-blind, multicentre study
    • Cepeda JA, Whitehouse T, Cooper B et al. Linezolid versus teicoplanin in the treatment of gram-positive infections in the critically ill: A randomised, double-blind, multicentre study. J Antimicrob Chemother 2004; 53: 345-355
    • (2004) J Antimicrob Chemother , vol.53 , pp. 345-355
    • Cepeda, J.A.1    Whitehouse, T.2    Cooper, B.3
  • 4
    • 20144385743 scopus 로고    scopus 로고
    • Pharmacokinetic studies of linezolid and teicoplanin in the critically ill
    • Whitehouse T, Cepeda JA, Shulman R et al. Pharmacokinetic studies of linezolid and teicoplanin in the critically ill. J Antimicrob Chemother 2005; 5: 333-340
    • (2005) J Antimicrob Chemother , vol.5 , pp. 333-340
    • Whitehouse, T.1    Cepeda, J.A.2    Shulman, R.3
  • 5
    • 0347694556 scopus 로고    scopus 로고
    • Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides and linezoid
    • Craig WA. Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides and linezoid. Infect Dis North America 2003; 17: 479-501
    • (2003) Infect Dis North America , vol.17 , pp. 479-501
    • Craig, W.A.1
  • 6
    • 0042925335 scopus 로고    scopus 로고
    • Pharmacokinetics of linezolid in subjects with renal dysfunction
    • Brier ME, Stalker DJ, Aronoff GR et al. Pharmacokinetics of linezolid in subjects with renal dysfunction. Antimicrob Agents Chemother 2003; 47: 2775-2780
    • (2003) Antimicrob Agents Chemother , vol.47 , pp. 2775-2780
    • Brier, M.E.1    Stalker, D.J.2    Aronoff, G.R.3
  • 7
    • 9344260227 scopus 로고    scopus 로고
    • Linezolid disposition after standard dosages in critically ill patients undergoing continuous venovenous hemofiltration: A report of 2 cases
    • Pea F, Viale P, Lugano M et al. Linezolid disposition after standard dosages in critically ill patients undergoing continuous venovenous hemofiltration: A report of 2 cases. Am J Kidney Dis 2004; 44: 1097-102
    • (2004) Am J Kidney Dis , vol.44 , pp. 1097-1102
    • Pea, F.1    Viale, P.2    Lugano, M.3
  • 8
    • 0041347955 scopus 로고    scopus 로고
    • Linezolid clearance during continuous venovenous hemodiafiltration: A case report
    • Kraft MD, Pasko DA, DePestel DD et al. Linezolid clearance during continuous venovenous hemodiafiltration: A case report. Pharmacotherapy 2003; 23: 1071-1075
    • (2003) Pharmacotherapy , vol.23 , pp. 1071-1075
    • Kraft, M.D.1    Pasko, D.A.2    DePestel, D.D.3
  • 9
    • 10644235852 scopus 로고    scopus 로고
    • Determination of linezolid clearance via continuous hemodiafiltration [abstract]
    • Mauro LS, Sharief I, Assaly R, Malhoura D. Determination of linezolid clearance via continuous hemodiafiltration [abstract]. Am J Kidney Dis 2001; 37: A77
    • (2001) Am J Kidney Dis , vol.37
    • Mauro, L.S.1    Sharief, I.2    Assaly, R.3    Malhoura, D.4
  • 10
    • 24044481321 scopus 로고    scopus 로고
    • Multiple-dose pharmacokinetics of linezolid during continuous venovenous hemofiltration
    • Meyer B, Kornek GV, Nikfardjam M et al. Multiple-dose pharmacokinetics of linezolid during continuous venovenous hemofiltration. J Antimicrob Chemother 2005; 56: 172-179
    • (2005) J Antimicrob Chemother , vol.56 , pp. 172-179
    • Meyer, B.1    Kornek, G.V.2    Nikfardjam, M.3
  • 11
    • 10644266022 scopus 로고    scopus 로고
    • Removal of linezolid by conventional intermittent hemodialysis, sustained low-efficiency dialysis, or continuous venovenous hemofiltration in patients with acute renal failure
    • Fiaccadori E, Maggiore U, Rotelli C et al. Removal of linezolid by conventional intermittent hemodialysis, sustained low-efficiency dialysis, or continuous venovenous hemofiltration in patients with acute renal failure. Crit Care Med 2004; 32: 2437-2442
    • (2004) Crit Care Med , vol.32 , pp. 2437-2442
    • Fiaccadori, E.1    Maggiore, U.2    Rotelli, C.3
  • 12
    • 33646177583 scopus 로고    scopus 로고
    • REML analysis of mixed models
    • Release 8. Statistic VSN International. Oxford, UK
    • Paine RW. REML analysis of mixed models, in The Guide to Genstat, Release 8. Part 2, Statistic VSN International. 2005. Oxford, UK
    • (2005) The Guide to Genstat , Issue.PART 2
    • Paine, R.W.1
  • 13
    • 0038440756 scopus 로고    scopus 로고
    • Pharmacokinetics and tolerance of single- and multiple dose oral or intravenous linezolid, an oxazolidinone antibiotic, in healthy volunteers
    • Stalker DJ, Jungbluth GL, Hopkins NK, Batts DH. Pharmacokinetics and tolerance of single- and multiple dose oral or intravenous linezolid, an oxazolidinone antibiotic, in healthy volunteers. J Antimicrob Chemother 2003; 51: 1239-1246
    • (2003) J Antimicrob Chemother , vol.51 , pp. 1239-1246
    • Stalker, D.J.1    Jungbluth, G.L.2    Hopkins, N.K.3    Batts, D.H.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.